Search Results - "Cattenoz, Catherine"
-
1
Prevalence and impact of frailty on mortality in elderly ICU patients: a prospective, multicenter, observational study
Published in Anaesthesia and intensive care medicine (01-05-2014)“…Purpose Frailty is a recent concept used for evaluating elderly individuals. Our study determined the prevalence of frailty in intensive care unit (ICU)…”
Get full text
Journal Article -
2
Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross‐sectional survey (NutriAgeCancer)
Published in Journal of cachexia, sarcopenia and muscle (01-12-2021)“…Background Nutritional impairment is common in cancer patients and is associated with poor outcomes. Only few studies focused on cachexia. We assessed the…”
Get full text
Journal Article -
3
Short course radiotherapy versus radiochemotherapy for locally advanced rectal cancers in the elderly (UNICANCER PRODIGE 42/GERICO 12 study): Quality of life and comprehensive geriatric assessment
Published in Radiotherapy and oncology (01-04-2024)“…•We have included Quality of Life analyses and oncogeriatric evaluations in the randomized trial for locally advanced rectal cancers in the elderly (PRODIGE…”
Get full text
Journal Article -
4
Identifying frailty in clinically fit patients diagnosed with hematological malignancies using a simple clinico-biological screening tool: The HEMA-4 study
Published in Journal of geriatric oncology (01-07-2021)“…This study aims to develop and validate a simple score to estimate survival in the older population suffering from malignant hemopathies. We prospectively…”
Get full text
Journal Article -
5
Inside the Black Box: A Narrative Review on Comprehensive Geriatric Assessment-Driven Interventions in Older Adults with Cancer
Published in Cancers (24-03-2022)“…There is a consensus that the use of comprehensive geriatric assessment (CGA) is good clinical practice for older patients with solid tumors or hematological…”
Get full text
Journal Article -
6
Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors
Published in Cancer chemotherapy and pharmacology (01-01-2015)“…Purpose Sorafenib is the standard of care for advanced hepatocellular carcinoma (HCC). The peak incidence of HCC is around 70 years. We aimed to evaluate…”
Get full text
Journal Article